fashion -WSS

fashion

author：entertainment 2025-10-01 13:58:30 - browse：14

Christopher Boerner -- biotech JPM coverage from STAT — Bristol CEO Christopher Boerner Business Wire via AP

SAN FRANCISCO — Christopher Boerner has been the CEO of Bristol Myers Squibb for just two months. But in trying to sell the company to investors on Monday at the annual J.P. Morgan Healthcare Conference, he pointed to the company’s 150-year history.

He spoke of the “next chapter” for BMS, which saw its stock fall 27% last year, and said that the company would be going through a “period of renewal.” Basically, the tide comes in, but it also goes out. Patents on big-selling medicines expire, but new medicines will come to take their place.

Investors may not be able to view those changes with equanimity. Sales of Bristol’s top sellers will decline significantly or vanish as generic or biosimilar medicines emerge. That includes Eliquis, the blood thinner for stroke prevention that will be one of the first medications subject to price negotiation under the Inflation Reduction Act; Revlimid, the best-selling multiple myeloma medicine that Bristol acquired when it bought Celgene for $74 billion in 2019; and Opdivo, Bristol’s pioneering cancer immunotherapy, which is an $8 billion seller.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： HHS secretary Becerra pressed on Change HealthCare cyberattack

leisure time

WSS

EPA limits use of carcinogenic gas for sterilizing medical devices

In boost for rare disease push, AstraZeneca to buy Amolyt Pharma

We're not in Australia anymore: Kansas cops jump into action to save kangaroo

President Biden's budget: Here's what you might have missed

HHS secretary Becerra pressed on Change HealthCare cyberattack

EPA limits use of carcinogenic gas for sterilizing medical devices

focus

fashion

explore

United colonoscopy coverage change 'may cost lives,' doctors say

Why depression after traumatic brain injury is distinct

The high cost of giving birth even with insurance

How to fix the rural physician shortage in the U.S.

Alkermes shareholders re

Pushing for an NIH office for post

Novavax promises a turnaround & Lilly roils the obesity market

Can medical device makers keep up in the race to treat obesity?

Anesthesiologist group: stop taking Ozempic before surgery

The thinking behind the controversial eating disorder chatbot Tessa

Wikipedia

Can medical device makers keep up in the race to treat obesity?

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

Medicare coverage of Wegovy, once blocked, now looks possible

Sea level rise could wash away turtle breeding grounds around the world, researchers say

FDA approves first new drug developed for postpartum depression

Xenotransplantation trials will require adjusting expectations, experts say

knowledge

explore

leisure time

Wikipedia